
Enovis Corporation
ENOVNYSEHealthcareMedical - Devices
Regular session
$26.325
+$0.265 · +1.02%
ENOV company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
50
Neutral
Sentiment
66
Bullish
Risk resilience
41
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteEnovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Damien McDonald
- Listed since
- May 8, 2008
- Employees
- 7,802
Market position
Day range
Current $26.325
52-week range
Current $26.325
- Open
- $26.28
- Previous close
- $26.06
- Volume
- 44.01K
- 0.04× average
- Average volume
- 1.15M
- Average daily volume
- Market cap
- 1.52B USD
- Beta
- 1.45
- Market reference 1
- 50-day average
- $25.1914
- +4.50% above average
- 200-day average
- $25.095
- +4.90% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.86B USD
- P/E (TTM)
- -1.36×
- P/B (TTM)
- 1.03×
- P/S (TTM)
- 0.66×
- EV / EBITDA
- -3.44×
- Earnings yield
- -78.29%
- Free cash flow yield
- 1.32%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 57.43%
- Operating margin
- 4.14%
- Net margin
- -47.97%
- Return on equity
- -79.51%
- Return on assets
- -30.89%
- Return on invested capital
- -0.57%
Financial health
- Debt / equity
- 0.93×
- Current ratio
- 2.02×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.25B USD | 2.11B USD | 1.71B USD | 1.56B USD | 1.43B USD |
| Cost of goods sold | 902.79M USD | 926.87M USD | 716.42M USD | 693.72M USD | 648.51M USD |
| Gross profit | 1.35B USD | 1.18B USD | 990.78M USD | 869.38M USD | 777.68M USD |
| Research and development | 120.33M USD | 91.3M USD | 75.33M USD | 60.83M USD | 49.09M USD |
| Selling, general, and administrative | 1.07B USD | 939.36M USD | 830.31M USD | 772.91M USD | 665.78M USD |
| Operating expenses | 1.36B USD | 1.96B USD | 1.06B USD | 940.56M USD | 840.47M USD |
| Interest income | — | — | — | 200K USD | — |
| Interest expense | 34.82M USD | 57.1M USD | 19.75M USD | 24.95M USD | 29.11M USD |
| Depreciation and amortization | 294.38M USD | 284.8M USD | 217.11M USD | 219.71M USD | 262.92M USD |
| Operating income | −18.87M USD | −775.72M USD | −65.71M USD | −71.18M USD | −62.8M USD |
| Net income | −1.18B USD | −825.49M USD | −33.26M USD | −13.29M USD | 71.66M USD |
Company facts updated Aug 24, 2026.
ENOV peers
ETFs holding ENOV
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR86.46M0.08%111.19B USD0.06%$147.17-0.10%
Vanguard Morningstar Total Stock Market ETFVTI50.7M0.00%2.3T USD0.03%$377.16-0.29%
Avantis U.S. Small Cap Value ETFAVUV46.26M0.15%31.27B USD0.25%$126.51+0.04%
iShares Russell 2000 ETFIWM38.48M0.05%81.62B USD0.19%$298.85-0.37%
Vanguard Morningstar Small-Cap ETFVB36.63M0.02%183.4B USD0.03%$303.64-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR23.27M0.03%68.3B USD0.05%$249.35+0.07%
Vanguard Extended Market ETFVXF19.31M0.02%93.7B USD0.05%$244.17-0.55%
iShares Russell 2000 Value ETFIWN14.07M0.10%14.66B USD0.24%$225.02+0.09%
iShares Core S&P Small-Cap ETFIJR- Market value
- 86.46M
- Weight
- 0.08%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.17-0.10%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 50.7M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.16-0.29%
Avantis U.S. Small Cap Value ETFAVUV- Market value
- 46.26M
- Weight
- 0.15%
- AUM
- 31.27B USD
- Expense ratio
- 0.25%
- Price / 1D
- $126.51+0.04%
iShares Russell 2000 ETFIWM- Market value
- 38.48M
- Weight
- 0.05%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $298.85-0.37%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 36.63M
- Weight
- 0.02%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $303.64-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 23.27M
- Weight
- 0.03%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.35+0.07%
Vanguard Extended Market ETFVXF- Market value
- 19.31M
- Weight
- 0.02%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $244.17-0.55%
iShares Russell 2000 Value ETFIWN- Market value
- 14.07M
- Weight
- 0.10%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $225.02+0.09%
Continue in GoAI
Research ENOVresearch.disclaimer





